Table 2

Associations between baseline and 1-year time-integrated measures of inflammation and 3-year change in radiographic damage (univariate linear regression analyses)

Independent variables: baseline measuresIndependent variables: 12 months AUC of inflammatory markers
β (95% CI)R2p Valueβ (95% CI)R2p Value
Baseline characteristics
 Female−0.36 (−0.96 to 0.25)0.020.24
 Age−0.002 (−0.02 to 0.02)0.0010.82
 Anti-CCP positivity0.50 (−0.16 to 1.15)0.040.13
Clinical measures of disease activity
 28-SJC0.03 (−0.03 to 0.08)0.010.310.01 (−0.001 to 0.02)0.060.07
 28-TJC−0.01 (−0.05 to 0.03)0.0040.57−0.002 (−0.01 to 0.005)0.010.56
 DAS280.14 (−0.05 to 0.32)0.030.150.02 (−0.01 to 0.05)0.030.19
Serological markers of inflammation
 ESR0.02 (0.01 to 0.04)0.090.010.004 (0.001 to 0.01)0.110.02
 CRP0.01 (−0.001 to 0.03)0.050.060.01 (0.001 to 0.01)0.090.03
MRI measures of inflammation
 MRI synovitis0.14 (0.01 to 0.26)0.060.030.03 (0.01 to 0.05)0.130.01
 MRI bone marrow oedema0.06 (0.02 to 0.10)0.080.010.01 (0.004 to 0.02)0.150.004
 MRI tenosynovitis−0.02 (−0.09 to 0.05)0.010.540.005 (−0.01 to 0.02)0.010.43
  • p≤0.05.

  • 28-SJC, 28-swollen joint count; 28-TJC, 28-tender joint count; anti-CCP, anti-citrullinated protein antibodies; AUC, area under the curve; CRP, C reactive protein; DAS28, disease activity score based on 28 joint counts; ESR, erythrocyte sedimentation rate; R2, fraction of explained variance; vdHSS, van der Heijde Sharp score.